270 related articles for article (PubMed ID: 24335852)
1. Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.
Green AL; Gu P; De Felice M; Dodick D; Ossipov MH; Porreca F
Cephalalgia; 2014 Jul; 34(8):594-604. PubMed ID: 24335852
[TBL] [Abstract][Full Text] [Related]
2. Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression.
Ingvardsen BK; Laursen H; Olsen UB; Hansen AJ
Pain; 1997 Sep; 72(3):407-15. PubMed ID: 9313281
[TBL] [Abstract][Full Text] [Related]
3. Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
Navratilova E; Behravesh S; Oyarzo J; Dodick DW; Banerjee P; Porreca F
Cephalalgia; 2020 Aug; 40(9):892-902. PubMed ID: 32615788
[TBL] [Abstract][Full Text] [Related]
4. Neural hyperactivity in the amygdala induced by chronic treatment of rats with analgesics may elucidate the mechanisms underlying psychiatric comorbidities associated with medication-overuse headache.
Wanasuntronwong A; Jansri U; Srikiatkhachorn A
BMC Neurosci; 2017 Jan; 18(1):1. PubMed ID: 28049513
[TBL] [Abstract][Full Text] [Related]
5. Cortical hyperexcitability and mechanism of medication-overuse headache.
Supornsilpchai W; le Grand SM; Srikiatkhachorn A
Cephalalgia; 2010 Sep; 30(9):1101-9. PubMed ID: 20713560
[TBL] [Abstract][Full Text] [Related]
6. Altered activity in the nucleus raphe magnus underlies cortical hyperexcitability and facilitates trigeminal nociception in a rat model of medication overuse headache.
Potewiratnanond P; le Grand SM; Srikiatkhachorn A; Supronsinchai W
BMC Neurosci; 2019 Oct; 20(1):54. PubMed ID: 31638891
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cutaneous allodynia following induction of cortical spreading depression in freely moving rats.
Fioravanti B; Kasasbeh A; Edelmayer R; Skinner DP; Hartings JA; Burklund RD; De Felice M; French ED; Dussor GO; Dodick DW; Porreca F; Vanderah TW
Cephalalgia; 2011 Jul; 31(10):1090-100. PubMed ID: 21700643
[TBL] [Abstract][Full Text] [Related]
8. Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas.
Becerra L; Bishop J; Barmettler G; Xie Y; Navratilova E; Porreca F; Borsook D
J Neurophysiol; 2016 Jan; 115(1):208-17. PubMed ID: 26490291
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.
Rau JC; Navratilova E; Oyarzo J; Johnson KW; Aurora SK; Schwedt TJ; Dodick DW; Porreca F
Cephalalgia; 2020 Aug; 40(9):903-912. PubMed ID: 32580575
[TBL] [Abstract][Full Text] [Related]
10. Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents.
Kopruszinski CM; Xie JY; Eyde NM; Remeniuk B; Walter S; Stratton J; Bigal M; Chichorro JG; Dodick D; Porreca F
Cephalalgia; 2017 May; 37(6):560-570. PubMed ID: 27206958
[TBL] [Abstract][Full Text] [Related]
11. Serotonin depletion leads to cortical hyperexcitability and trigeminal nociceptive facilitation via the nitric oxide pathway.
le Grand SM; Supornsilpchai W; Saengjaroentham C; Srikiatkhachorn A
Headache; 2011; 51(7):1152-60. PubMed ID: 21649655
[TBL] [Abstract][Full Text] [Related]
12. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan.
Read SJ; Hirst WD; Upton N; Parsons AA
Brain Res; 2001 Feb; 891(1-2):69-77. PubMed ID: 11164810
[TBL] [Abstract][Full Text] [Related]
13. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.
Moskowitz MA; Nozaki K; Kraig RP
J Neurosci; 1993 Mar; 13(3):1167-77. PubMed ID: 8382735
[TBL] [Abstract][Full Text] [Related]
14. The thalamic reticular nucleus is activated by cortical spreading depression in freely moving rats: prevention by acute valproate administration.
Tepe N; Filiz A; Dilekoz E; Akcali D; Sara Y; Charles A; Bolay H
Eur J Neurosci; 2015 Jan; 41(1):120-8. PubMed ID: 25327971
[TBL] [Abstract][Full Text] [Related]
15. Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery.
Cottier KE; Galloway EA; Calabrese EC; Tome ME; Liktor-Busa E; Kim J; Davis TP; Vanderah TW; Largent-Milnes TM
eNeuro; 2018; 5(4):. PubMed ID: 30073201
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between CSD-Evoked Metabolic Perturbations and Meningeal Afferent Activation and Sensitization: Implications for Mechanisms of Migraine Headache Onset.
Zhao J; Levy D
J Neurosci; 2018 May; 38(22):5053-5066. PubMed ID: 29703787
[TBL] [Abstract][Full Text] [Related]
17. Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache.
Supornsilpchai W; le Grand SM; Srikiatkhachorn A
Headache; 2010 Feb; 50(2):185-97. PubMed ID: 20039957
[TBL] [Abstract][Full Text] [Related]
18. CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior.
Filiz A; Tepe N; Eftekhari S; Boran HE; Dilekoz E; Edvinsson L; Bolay H
Cephalalgia; 2019 Mar; 39(3):354-365. PubMed ID: 28971699
[TBL] [Abstract][Full Text] [Related]
19. Triptan-induced latent sensitization: a possible basis for medication overuse headache.
De Felice M; Ossipov MH; Wang R; Lai J; Chichorro J; Meng I; Dodick DW; Vanderah TW; Dussor G; Porreca F
Ann Neurol; 2010 Mar; 67(3):325-37. PubMed ID: 20373344
[TBL] [Abstract][Full Text] [Related]
20. Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system.
Lambert GA; Truong L; Zagami AS
Cephalalgia; 2011 Oct; 31(14):1439-51. PubMed ID: 21940490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
